The ROE as of November 2024 (TTM) for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is 2.60%

According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current ROE is 2.60%. This represents a change of 17.44% compared to the average of 2.21% of the last 4 quarters.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Historical ROE (quarterly & annually)

How has GNMLF ROE performed in the past?

The mean historical ROE of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 6.65%. The current 2.60% ROE has changed -60.96% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's ROE was at its highest in in the June 2024 quarter at 5.97%. The ROE was at its lowest in in the December 2023 quarter at -1.23%.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) ROE by Quarter and Year

Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Average ROE

How has GNMLF ROE performed in the past?

The current ROE of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) ROE vs. Peers

How is GNMLF’s ROE compared to its peers?

Genomma Lab Internacional, S.A.B. de C.V.’s ROE is less than RAMM Pharma Corp. (0%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), less than City View Green Holdings Inc. (65.45%), greater than Craftport Cannabis Corp. (-194.22%), less than Hypera S.A. (13.22%), less than Indivior PLC (4.23%), greater than YourWay Cannabis Brands Inc. (0%), greater than Cumberland Pharmaceuticals Inc. (-40.17%), greater than Orexo AB (publ) (-359.08%), greater than Sumitomo Pharma Co., Ltd. (-97.03%), less than Indivior PLC (4.23%), greater than C21 Investments Inc. (-14.98%), greater than RavenQuest BioMed Inc. (-203.42%), less than Bhang Inc. (400.77%), greater than Willow Biosciences Inc. (-325.63%), greater than Alpha Teknova, Inc. (-37.32%), less than Guardion Health Sciences, Inc. (77.24%), less than Lifecore Biomedical, Inc. (17.23%), greater than Organogenesis Holdings Inc. (-2.69%), greater than Petros Pharmaceuticals, Inc. (-76.66%),

Build a custom stock screener for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.